Skip Navigation


European Heart Journal Advance Access originally published online on June 17, 2005
European Heart Journal 2005 26(14):1345-1346; doi:10.1093/eurheartj/ehi354
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/14/1345    most recent
ehi354v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Grohé, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grohé, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

‘Tib the balance’: the search for the optimal hormone replacement therapy

Christian Grohé*

Medizinische Universitäts-Poliklinik, Universitätsklinikum Bonn, Wilhelmstrasse 35–37, 53111 Bonn, Germany

* Corresponding author. Tel: +49 228 287 2263; fax: +49 228 287 2204. E-mail address: c.grohe@uni-bonn.de

This editorial refers to ‘Menopausal complaints, oestrogens, and heart disease risk: an explanation for discrepant findings on the benefits of post-menopausal hormone therapy’{dagger} by Y.T. van der Schouw et al., on page 1358 and ‘Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study’{ddagger} by K.K. Koh et al., on page 1362

The first 10% of the full text of this article appears below.

In 1902, W. Bayliss and E. Starling formulated a new term in their effort to prove the existence of internal secretions. The selected term ‘hormone’ was phrased after the Greek word for ‘I excite’.1

Since these early observations about the physiological relevance of sex hormone regulation, the excitement in this field of research and related therapy has never really stopped. On the one hand, we have learnt a lot about the complex regulatory network of sex hormones and their respective receptors in heart disease.2 On the other, in parallel with the growing knowledge about hormones, . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Menopausal complaints, oestrogens, and heart disease risk: an explanation for discrepant findings on the benefits of post-menopausal hormone therapy
Yvonne T. van der Schouw and Diederick E. Grobbee
EHJ 2005 26: 1358-1361. [Abstract] [Full Text]  

Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study
Kwang Kon Koh, Seung Hwan Han, Mi-Seung Shin, Jeong Yeal Ahn, Yonghee Lee, and Eak Kyun Shin
EHJ 2005 26: 1362-1368. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. Kappert, E. Caglayan, M. Huntgeburth, A. T. Baumer, J. Sparwel, M. Uebel, and S. Rosenkranz
17{beta}-Estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H538 - H546.
[Abstract] [Full Text] [PDF]